HEMODİYALİZE GİREN KRONİK BÖBREK YETMEZLİKLİ OLGULARDA TÜBERKÜLİN DERİ TESTİNİN DEĞERLENDİRİLMESİ

Yıl 2010, Cilt: 24 Sayı: 3, 165 - 171, 01.12.2010

Pervaneh Şeber Feride Sapmaz Nalan Akalın

Öz

Tüberküloz (tüberküloz) taramasında kullanılan tüberkülin deri testinin (TDT) hemodiyaliz (HD) uygulanan kronik böbrek yetmezlik (KBY)'li olgularda genel topluma göre yüksek oranda negatif bulunması, bu testin güvenirliliğini gölgelemektedir. Bu çalışmanın amacı; HD'e giren KBY'li olgularda, tüberküloz enfeksiyonu taranırken, TDT'nin değerlendirilmesi ve aynı zamanda BCG aşısı, HD süresi, hepatit markerleri ile TDT arasında korelasyon olup olmadığına bakılması idi. KBY'li 82 HD hastasına TDT yapıldı. Aynı zamanda BCG aşısı, HD süresi, hepatit markerlerine bakıldı. TDT olguların 38 (%46.3)'inde pozitif, 44 (%53.7) ise negatif olup, TDT'nin yalancı negatiflik oranı %53.7 olarak bulundu. BCG aşısı, hepatit taşıyıcılığı ve HD süreleri ile TDT arasında bir korelasyon tespit edilmedi KBY'li olgularda hücresel immünitedeki azalma nedeni anerjinin sık görülür. Bu nedenle TDT'nin yararı diğer çalışmalarda olduğu gibi bu çalışmada da tüberküloz infeksiyonu tanısında yetersiz olduğu düşünülmektedir.

Anahtar Kelimeler

Kronik böbrek yetmezliği, tüberkülin deri testi, hemodiyaliz

EVALUATING TUBERCULIN SKIN TEST IN CHRONIC RENAL FAILURE PATIENTS UNDERGOING HEMODIALYSIS

Öz

Negative results of tuberculin skin test (TST) which used searching for tuberculosis in patients who require hemodialysis (HD) treatment because of chronic renal failure (CRF) make suspects about its safe. Aim of this study was evaluating TST and researching correlation between this test and BCG vaccination, HD period, hepatitis markers if there is any. TST were 82 HD patients CRF. At the same time, hepatitis markers were studied and HD period, BCG vaccination status were noted. TST is positive in 38 (%46.3) and negativite in 44 (%53.7). False negative ratio was %53.7. There was no corelation between BCG vaccination, hepatitis carrier, HD period TST. Anergia is common in patients with CRF, because of reduced cellular immunity. Because of, if it was thought that diagnostic value of TST is inadequate in diagnosis of tuberculosis in CRF patients which represent decreased cellular immunity and are frequently anergic, Conclusions: TST is insufficient in detecting tüberküloz infection which this is similar to other studies and also there is no correlation found between TST and BCG vaccination, hepatitis carriers and HD periods.

Anahtar Kelimeler

Chronic renal failure, tuberculin skin test, hemodialysis

Kaynakça

• 1. Reichman LB. A scandalous incompetence… continued. Chest 1998; 113: 1153-4.
• 2. Fishman, AP. Clinical Pulmonary Diseases and Disorders Forms of Mycobacterial Disease. second In: Jhon G. Weg, ed., ed., New York: McGraw-Hill Company, 1988. P1845.
• 3. Murhty BV, Pereira BJ: A 1990s perspective of hepatitis C, human immunodeficiency virus, and tuberculosis infection in dialysis patient. Semin Nephrol 1997; 17: 346-63.
• 4. Snider DE. Bacille Calmette-Guerin vaccinations and tuberculin skin test. JAMA 1985; 253: 3438-9.
• 5. Pradhan RP, Katz LA, Nidus BD, Matalon R, Eisinger RP. Tuberculosis in dialyzed patients. JAMA 1974; 229: 798-800.
• 6. Hussein MM, Mooij JM, Roujouleh H. Tuberculosis and chronic renal disease. Semin Dial 2003; 16: 38-44.
• 7. Sasaki S, Akiba T, Suenaga M, Tomura S, Yoshiyama N, Nakagawa S, et al. Ten years' survey of dialysis-associated tuberculosis. Nephron 1979; 24: 141-5.
• 8. Nash DR, Douglass JE. Anergy in active pulmonary tuberculosis. A comparison between positive and negative reactors and an evaluation of 5 TU and 250 TU skin test doses. Chest 1980; 77: 32-7.
• 9. Sbarbaro JA. Skin test antigens: an evaluation whose time has come. Am Rev Respir Dis 1978; 118: 1-5.
• 10. Gökçay G. Tüberküloz. Say› 11. ‹stanbul. Aves yay›nc›l›k. 2010. 206-14.
• 11. Woeltje KF, Mathew A, Rothstein M, Seiler S, Fraser VJ. Tuberculosis infection and anergy in hemodialysis patients. Am J Kidney Dis 1998; 31: 848-52.
• 12. Chan J, Kaufmann: Immune mechanisms of protection. Tuberculosis, Pathogenesis, Protection and Control (Ed. Blomm BR). Washington: ASM Press 1994: 389-416.
• 13. Huebner RE, Schein MF, Cauthen GM, Geiter LJ, Selin MJ, Good RC et al. Evaluation of clinical usefulness of mycobacterial skin test antigens in adults with pulmonary mycobacterioses. Am Rev Respir Dis 1992; 145: 1160-6.
• 14. Wauters A, Peetermans WE, Van den Brande P, De Moor B, Evenepoel P, Keuleers H, et al. The value of tuberculin skin testing in haemodialysis patients. Nephrol Dial Transplant 2004; 19: 433-8.
• 15. Starkey RD. Tuberculin testing: placement and interpretation. AAOHN J 1995; 43: 371-5.
• 16. Lordi GM, Reichman LB. Tüberkülin deri testi. In: Schlossberg D (ed). Tüberküloz. Tetikkurt C. (Çeviri ed). ‹stanbul: Bilimsel ve Teknik Yay›nlar› Çeviri Vakf› Bas›m ve Ciltevi 1995: 47-51.
• 17. Diel R, Ernst M, Döscher G, Visuri-Karbe L, Greinert U, Niemann S, et al. Avoiding the effect of BCG vaccination in detecting Mycobacterium tuberculosis infection with a blood test. Eur Respir J 2006; 28: 16-23.
• 18. Comstock GW. False tuberculin test results. Chest 1975; 68 (3 SUPPL): 465-9.
• 19. Barnes PF. Diagnosing latent tuberculosis infection: the 100-year upgrade. Am J Respir Crit Care Med 2001; 163: 807-8.
• 20. Eleftheriadis T, Antoniadi G, Liakopoulos V, Kartsios C, Stefanidis I.Disturbances of acquired immunity in hemodialysis patients. Semin Dial 2007; 20: 440-51.
• 21. CDC: Screening for tuberculosis and tuberculosis infection in high-risk population. MMWR 1995; 44 (RR-11).
• 22. Tokars JI, Miller ER, Alter MJ, Arduino MJ: National surveillance of dialysis associated in the United States, 1995. ASIO J 1998; 44: 98-107
• 23. Goldblum SE, Reed WP. Host defenses and immunologic alterations associated with chronic hemodialysis Ann Intern Med 1980; 93: 597-13.
• 24. Smirnoff M, Patt C, Seckler B, Adler JJ: Tuberculin and anergy skin testing of patients receiving long-term hemodialysis. Chest 1998; 113: 25-7.
• 25. Cengiz K. Increased incidence of tuberculosis in patients undergoing hemodialysis. Nephron 1996; 73: 421-4.
• 26. Kayabasi H, Sit D, Kadiroglu AK, Kara IH, Yilmaz ME. The prevalence and the characteristics of tuberculosis patients undergoing chronic dialysis treatment: experience of a dialysis center in southeast Turkey. Ren Fail 2008; 30: 513-9.
• 27. Segall L, Covic A. Diagnosis of tuberculosis in dialysis patients: current strategy. Clin J Am Soc Nephrol 2010; 5: 1114-22.
• 28. Kürflat S, Ozgür B. Increased incidence of tuberculosis in chronic hemodialysis patients. Am J Nephrol 2001; 21: 490-3.
• 30. Baflo¤lu K.Ö, Atasever A, Telli G.C, Özol D, Aflç› G, Ardeniz Ö ve ark. Kronik böbrek yetmezlikli olgularda tüberkülin cilt testi yan›t› ve T-lenfosit alt gruplar›.Tüberküloz ve Toraks Dergisi 2006; 54: 5-10.
• 31. Taflbakan MS, Say›ner A.Tüberküloz hastal›¤› ve infeksiyonunda interferon gamma testlerinin yeri. ‹nfeksiyon Dergisi (Turkish Journal of Infection) 2008; 22: 179-84.
• 32. Lee SS, Chou KJ, Dou HY, Huang TS, Ni YY, Fang HC et al. High prevalence of latent tuberculosis infection in dialysis patients using the interferon-gamma release assay and tuberculin skin test.. Clin J Am Soc Nephrol 2010; 5: 1451-7.